Minimize Uncertainty – Make Informed Decisions – Succeed

Respiratory

Respiratory Today—February 6, 2026

February 6, 2026telacebec,MicuRx,BioPharma and Tech News,ENA Respiratory,Idiopathic Pulmonary Fibrosis,MiNK Therapeutics,ATyr Pharma,Pulmonary Sarcoidosis,Eosinophilic Asthma,pulmonary arterial hypertension,Respiratory News,Wave Life Sciences,TB Alliance,Alpha-1 antitrypsin deficiency,Cereno Scientific,Lupinnon-tuberculous mycobacterial infection,Kymera Therapeutics

This week's Respiratory update covers regulatory engagement plans, clinical…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Eli Lilly Pipeline Rationalization

February 6, 2026Oncology,clinical trials,neurology,gene therapy,Regulatory,immunology,biopharma,Lucid Diligence Brief,payer access,diligence,genetic medicinesradioligand therapy

Lucid Diligence Brief: Eli Lilly Pipeline Rationalization Professional…

by Timos Papagatsias

ISC 2026 Preview: Key Highlights to Watch

February 5, 2026Our Insights,stroke recoveryAtrial fibrillation,Conference Previews,stroke research,Acute ischemic stroke,ISC 2026,International Stroke Conference,intracerebral hemorrhage,endovascular thrombectomy,secondary stroke prevention,artificial intelligence in stroke,machine learning in neurology,cerebrovascular disease

ISC 2026 at a Glance Get ready for ISC 2026. LucidQuest’s preview brings…

by LucidQuest

Lucid Diligence Brief - Tech

Lucid Diligence Brief: Medtronic intent to acquire CathWorks

February 5, 2026clinical trials,reimbursement,Regulatory,cardiovascular,Lucid Diligence Brief,payer access,diligence,M&A,Interventional cardiology,biopharma devicescoronary physiology

Lucid Diligence Brief: Medtronic intent to acquire CathWorks Professional…

by Timos Papagatsias

Cell_Gene_Therapy

Cell and Gene Therapy Video Recap—February 5, 2026

February 5, 2026Taysha,crispr,FDA,astrazeneca,BioPharma and Tech News,Lymphoma,CAR NK,Ultragenyx,Rett syndrome,Cell and Gene Therapy News,ImmunityBio,REGENXBIO,WugenANKTIVA,Intellia

This biweekly Cell and Gene Therapy video recap summarizes key developments,…

by LucidQuest

Cell_Gene_Therapy

Cell and Gene Therapy Today—February 5, 2026

February 5, 2026gene therapy,astrazeneca,Cell Therapy,BioPharma and Tech News,Stargardt Disease,Sanfilippo Syndrome,Ultragenyx,Rett syndrome,Cell and Gene Therapy News,AAV Gene TherapyCAR-NK cell therapy,Indolent lymphoma

This week's Cell and Gene Therapy updatehighlights key regulatory actions,…

by LucidQuest

Cardiovascular

Cardiovascular Today—Februrary 5, 2026

February 5, 2026BioPharma and Tech News,HEART FAILUREstroke,GE HealthCare,Medtronic,Cardiovascular News,coronary artery disease,medical imaging,Paroxysmal supraventricular tachycardia,Aortic arch disease,Artificial intelligence in cardiology

This is the weekly update in cardiovascular medicine, summarizing key…

by LucidQuest

Rare Disease news

Rare Diseases Today—February 5, 2026

February 5, 2026sanofi,Fabry Disease,Moderna,BioPharma and Tech News,mRNA therapies,Rare Disease News,Type 3 Gaucher disease,Propionic acidemia,Genetic therapies,Enzyme replacement therapyRare disease advocacy,Eton Pharmaceuticals

This weekly update in rare diseases highlights key developments in regulatory…

by LucidQuest

Immunology

Immunology Today—February 4, 2026

February 4, 2026astrazeneca,sanofi,immunotherapy,Atopic Dermatitis,BioPharma and Tech News,autoimmune diseases,Biogen,Immunology News,Systemic lupus erythematosusgraft-versus-host disease,Cutaneous lupus erythematosus

This weekly update in immunology covers significant developments in the field,…

by LucidQuest

Women's_Health

Women’s Health Video Recap—February 4, 2026

February 4, 2026Anifrolumab,Saphnelo,migraine,Mayzent,Teva,litifilimab,BioPharma and Tech News,BDCA2,MS,cutaneous lupus,Alzheimers,Taliban,Lupus,NorLevo,menopause,emergency contraception,Japan,Women's Health News,cladribine,BioNxt,Triple-negative breast cancerVyepti,Datroway

This biweekly Women’s Health video roundup covers the latest developments in…

by LucidQuest

Neuroscience

Neuroscience Video Recap—February 4, 2026

February 4, 2026Neurocrine Biosciences,Vyepti,migraine,Type 3 Gaucher disease,multiple sclerosis,ADHD,Teva,NBI-1065890,abbvie,VMAT2 inhibitors,novartis,sublingual delivery,sanofi,REYOBIQ,BioPharma and Tech News,CNS cancers,Lundbeck,CNSide,Plus Therapeutics,venglustat,Neuroscience News,Centanafadine,cladribine,Love in Mind,BioNxt,INFUSE study,Tardive dyskinesiaMayzent,Otsuka

This biweekly Neuroscience video recap covers key updates, including regulatory…

by LucidQuest

Neuroscience

Neuroscience Today—February 4, 2026

February 4, 2026Type 3 Gaucher disease,ADHD,migraine,CNS disorders,multiple sclerosis,siRNA delivery,gene therapy,Vect-Horus,Teva,OliX Pharmaceuticals,abbvie,SEQSTER,novartis,Apollo Neuroscience,sanofi,real-world evidence,BioPharma and Tech News,Lundbeck,Neuroscience News,OtsukaPraxis Precision Medicines,GENIXCURE

This week's Neuroscience update summarizes key developments in clinical…

by LucidQuest

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.